MyFinsight
Home
About
Contact
Back
Income Statement
EyePoint Pharmaceuticals, Inc. (EYPT)
source: myfinsight.com
Download
Download image
Comprehensive income (loss)
-$59,517K
Net loss
-$59,426K
Unrealized gain (loss) on
available-for-sale securities
-$91K
Interest and other
income, net
$2,894K
Net loss before
income taxes
-$59,333K
Provision for income taxes
$93K
Total other income,
net
$2,894K
License And
Collaboration Agreement
$5,333K
Loss from operations
-$62,227K
Total revenues
$5,333K
Total operating
expenses
$67,560K
Cost of sales
$165K
General and
administrative
$11,862K
Research and development
$55,498K
Sales and marketing
$35K
Back